64 related articles for article (PubMed ID: 35048639)
21. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
[TBL] [Abstract][Full Text] [Related]
22. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
23. Consistency of cytology diagnosis for cervical cancer between two laboratories.
Sriamporn S; Kritpetcharat O; Nieminen P; Suwanrungraung K; Kamsa-ard S; Parkin DM
Asian Pac J Cancer Prev; 2005; 6(2):208-12. PubMed ID: 16101335
[TBL] [Abstract][Full Text] [Related]
24. Cancer diagnosis after a report of negative cervical cytology.
Mitchell HS; Giles GG
Med J Aust; 1996 Mar; 164(5):270-3. PubMed ID: 8628160
[TBL] [Abstract][Full Text] [Related]
25. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
[TBL] [Abstract][Full Text] [Related]
26. Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
Doxtader EE; Brainard JA; Underwood D; Chute DJ
Cancer Cytopathol; 2017 Jan; 125(1):60-69. PubMed ID: 27731938
[TBL] [Abstract][Full Text] [Related]
27. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
[TBL] [Abstract][Full Text] [Related]
28. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
29. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
30. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
31. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
32. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
33. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Fourier-transform infrared spectroscopic screening of exfoliated cervical cells with standard Papanicolaou screening.
Fung Kee Fung M; Senterman M; Eid P; Faught W; Mikhael NZ; Wong PT
Gynecol Oncol; 1997 Jul; 66(1):10-5. PubMed ID: 9234913
[TBL] [Abstract][Full Text] [Related]
35. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
[TBL] [Abstract][Full Text] [Related]
36. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
[TBL] [Abstract][Full Text] [Related]
37. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
38. A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images.
William W; Ware A; Basaza-Ejiri AH; Obungoloch J
Biomed Eng Online; 2019 Feb; 18(1):16. PubMed ID: 30755214
[TBL] [Abstract][Full Text] [Related]
39. Pilot Study of an Open-source Image Analysis Software for Automated Screening of Conventional Cervical Smears.
Sanyal P; Ganguli P; Barui S; Deb P
J Cytol; 2018; 35(2):71-74. PubMed ID: 29643651
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
